At Stallergenes Greer,
we partner with Health
Care Professionals to
support patients
through their
treatment cycle
we partner with Health
Care Professionals to
support patients
through their
treatment cycle
Go Inside Staloral
Producto no registrado en España
2024_013EN01_May 2024
2024_013EN01_May 2024
Staloral® allergen extracts
mimic the diverse real-life
exposure of respiratory
allergic patients1-3
mimic the diverse real-life
exposure of respiratory
allergic patients1-3
Highly potent,4* Staloral®
demonstrated early 1st results
and meaningful improvements
over time for patients5-8
demonstrated early 1st results
and meaningful improvements
over time for patients5-8
Staloral® is a fully customisable
sublingual immunotherapy solution
that improves tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma5-11
sublingual immunotherapy solution
that improves tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma5-11
Staloral® has been evaluated in
over 30 studies and has shown
carry-over effects for up to 6 years after
treatment cessation, even preventing
allergy worsening6*,11**
over 30 studies and has shown
carry-over effects for up to 6 years after
treatment cessation, even preventing
allergy worsening6*,11**
Let's get personal
*Stallergenes Greer in vitro study. Data based on HDM Staloral.
Highly potent based on allergen potency evaluated quantitatively without any validated clinical consequences.
Highly potent based on allergen potency evaluated quantitatively without any validated clinical consequences.
*Results compared Staloral (grass pollen extract) and Staloral (HDM extracts) with placebo, in a subpopulation of elderly (≥60 years of age) patients
**In this study Staloral® (Birch extract) was investigated as one product in a treatment group compared to a non-AIT
control group and is based on a retrospective German database analysis of health and prescription data.
**In this study Staloral® (Birch extract) was investigated as one product in a treatment group compared to a non-AIT
control group and is based on a retrospective German database analysis of health and prescription data.
“Hi I’m Sonke and I’m a
P.E. (Physical Education)
teacher. The athletics and
birch-pollen seasons
overlap, this is when my
students need me the
most but my school work
and ability to concentrate
are impacted by my AR
(Allergic Rhinitis)."
P.E. (Physical Education)
teacher. The athletics and
birch-pollen seasons
overlap, this is when my
students need me the
most but my school work
and ability to concentrate
are impacted by my AR
(Allergic Rhinitis)."
Treat him
The following medical history is fictional. The presentation is based on
typically occurring
circumstances. The treatment and the success of the therapy depicted represent an idealized
course. This possible course of therapy has been confirmed by clinical studies. Nevertheless, each
patient and each course of disease is highly individual and a corresponding effect cannot be
expected and guaranteed for all patients.
circumstances. The treatment and the success of the therapy depicted represent an idealized
course. This possible course of therapy has been confirmed by clinical studies. Nevertheless, each
patient and each course of disease is highly individual and a corresponding effect cannot be
expected and guaranteed for all patients.
45 years old German
male, P.E. Teacher
Divorced, 3 children,
pets (cats, dogs)
Specialized in athletics
Before
"I experience AR symptoms
exclusively during the birch-
pollen season. Additionally, I
have developed OAS (Oral
Allergy Syndrome), leading to
oral itching when I consume
celery and fruits like apples,
pears, and plums. To manage
my AR, I rely on significant
amounts of symptomatic
medication. However, I am
currently facing challenges in
adequately preparing my
students for the local Junior
Athletics Championship."
exclusively during the birch-
pollen season. Additionally, I
have developed OAS (Oral
Allergy Syndrome), leading to
oral itching when I consume
celery and fruits like apples,
pears, and plums. To manage
my AR, I rely on significant
amounts of symptomatic
medication. However, I am
currently facing challenges in
adequately preparing my
students for the local Junior
Athletics Championship."
Help him to live a life beyond allergy
Clinical History
For almost 15 years, he has been suffering
from violent itchy eyes and runny
nose
from March to
August with mild symptoms
in Autumn, he is particularly struggling
with
symptoms control in March-April.
After a few years without treatment, he
received oral H1-antihistamine
and
corticosteroids eye drops.
Later, he experiencedworsening of
rhinoconjunctivitis symptoms
associated
with fatigue, headache and oral syndrome
(lip swelling,
throat
discomfort) when
eating apples and was dispensed oral
corticosteroids.
Clinical Exam
mild itchy eyes and
runny nose
no wheeze
Diagnosis
Diagnosis:
Allergic rhinitis to grass and
birch pollen with oral allergy
syndrome.
Birch pollen allergy associated
with the most bothersome
symptoms.
birch pollen with oral allergy
syndrome.
Birch pollen allergy associated
with the most bothersome
symptoms.
Treat
Physician
Recommendation
Recommendation
Allergen avoidance
Symptomatic Treatment
Subcutaneous immunotherapy
Sublingual
immunotherapy
liquid formulation
immunotherapy
liquid formulation
Sublingual
immunotherapy
tablet formulation
immunotherapy
tablet formulation
Patient's Choice
Symptomatic
Treatment
Sublingual immunotherapy
liquid formulation
Initiate Treatment
Early results
“Yesterday, I spent the whole day with
my school colleagues in the park for
our annual BBQ end-of-school party, I
finally feel like I can achieve my full
potential in school and on the track
with my students!”
my school colleagues in the park for
our annual BBQ end-of-school party, I
finally feel like I can achieve my full
potential in school and on the track
with my students!”
Maintenance
Maintained
Results
Results
“It's a whole year since I finished
AIT and I just had the best ever
early summer holiday with my
children. We went camping and zip-
lining in the forest. On our way
back home, we're going to spend
some more days in the campsite
near the city where I was born. It's
really good that I don't have to be
worried as before about allergies
when I go outside so I can show
them the places I grew in as a kid.”
AIT and I just had the best ever
early summer holiday with my
children. We went camping and zip-
lining in the forest. On our way
back home, we're going to spend
some more days in the campsite
near the city where I was born. It's
really good that I don't have to be
worried as before about allergies
when I go outside so I can show
them the places I grew in as a kid.”
Life beyond allergy
Every patientdeserves to live a life beyond allergy
Potential AIT benefits over time
Theoretical concept adapted with permission from Spriggs K. et al.12
Staloral® is a fully customisable
sublingual immunotherapy solution
that optimises tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma5-11
sublingual immunotherapy solution
that optimises tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma5-11
Highly potent,4* Starolar® demonstrated
early 1st results and meaningful
improvements overt time for patients5-8
early 1st results and meaningful
improvements overt time for patients5-8
Staloral® has been evaluated
in over 30 studies and has
shown carry-over effects for
up to 6 years after treatment
cessation, even preventing
allergy worsening6**,11***
in over 30 studies and has
shown carry-over effects for
up to 6 years after treatment
cessation, even preventing
allergy worsening6**,11***
Learn more about safety
*Stallergenes Greer in vitro study. Data based on HDM Staloral. Highly potent based on allergen potency evaluated quantitatively without any validated clinical consequences.
**Results compared Staloral (grass pollen extract) and Staloral (HDM extracts) with placebo, in a subpopulation of elderly (≥60 years of age) patients.
***In this study Staloral (Birch extract) was investigated as one product in a treatment group compared to a non-AIT control group and is based on a retrospective German database
analysis of health and prescription data.
**Results compared Staloral (grass pollen extract) and Staloral (HDM extracts) with placebo, in a subpopulation of elderly (≥60 years of age) patients.
***In this study Staloral (Birch extract) was investigated as one product in a treatment group compared to a non-AIT control group and is based on a retrospective German database
analysis of health and prescription data.
Every patientdeserves to live a life beyond allergy
Summary of the safety profile9
During treatment, patients are exposed to allergens that may induce
reactions which can occur immediately after administration or be delayed.
As with any allergen immunotherapy, severe allergic reactions including
severe laryngopharyngeal disorder or systemic allergic reactions (i.e. acute
onset of an illness with involvement of the skin, mucosal tissue, or both,
respiratory compromise, persistent gastrointestinal symptoms, or reduced
blood pressure and/or associated symptoms) can occur.
Inform patients of the associated signs and symptoms and have them seek
immediate medical care and discontinue therapy should these occur.
Treatment should only be resumed at the instruction of a
physician. Please consult section 4.8 of the SmPC for full safety details.
reactions which can occur immediately after administration or be delayed.
As with any allergen immunotherapy, severe allergic reactions including
severe laryngopharyngeal disorder or systemic allergic reactions (i.e. acute
onset of an illness with involvement of the skin, mucosal tissue, or both,
respiratory compromise, persistent gastrointestinal symptoms, or reduced
blood pressure and/or associated symptoms) can occur.
Inform patients of the associated signs and symptoms and have them seek
immediate medical care and discontinue therapy should these occur.
Treatment should only be resumed at the instruction of a
physician. Please consult section 4.8 of the SmPC for full safety details.
Let us tell you all about it
STALORAL as STALORAL or STALORAL 300 is a sublingual solution of allergen extracts for allergen immunotherapy.
•indicated for Type I allergies (Gell and Coombs classification) mainly involving rhinitis, conjunctivitis, rhino-conjunctivitis or asthma (mild to moderate) of a seasonal nature or perennial nature.
• registered in 22 countries (11 countries in European Union … Read more Read less
•indicated for Type I allergies (Gell and Coombs classification) mainly involving rhinitis, conjunctivitis, rhino-conjunctivitis or asthma (mild to moderate) of a seasonal nature or perennial nature.
• registered in 22 countries (11 countries in European Union … Read more Read less
.svg)
